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ABSTRACT
Objectives: To estimate data loss and bias in studies
of Clinical Practice Research Datalink (CPRD) data that
restrict analyses to Read codes, omitting anything
recorded as text.
Design: Matched case–control study.
Setting: Patients contributing data to the CPRD.
Participants: 4915 bladder and 3635 pancreatic,
cancer cases diagnosed between 1 January 2000 and
31 December 2009, matched on age, sex and general
practitioner practice to up to 5 controls (bladder:
n=21 718; pancreas: n=16 459). The analysis period
was the year before cancer diagnosis.
Primary and secondary outcome measures:
Frequency of haematuria, jaundice and abdominal pain,
grouped by recording style: Read code or text-only (ie,
hidden text). The association between recording style
and case–control status (χ2 test). For each feature, the
odds ratio (OR; conditional logistic regression) and
positive predictive value (PPV; Bayes’ theorem) for
cancer, before and after addition of hidden text records.
Results: Of the 20 958 total records of the features,
7951 (38%) were recorded in hidden text. Hidden text
recording was more strongly associated with controls
than with cases for haematuria (140/336=42% vs 556/
3147=18%) in bladder cancer (χ2 test, p<0.001), and
for jaundice (21/31=67% vs 463/1565=30%, p<0.0001)
and abdominal pain (323/1126=29% vs 397/
1789=22%, p<0.001) in pancreatic cancer. Adding
hidden text records corrected PPVs of haematuria for
bladder cancer from 4.0% (95% CI 3.5% to 4.6%) to
2.9% (2.6% to 3.2%), and of jaundice for pancreatic
cancer from 12.8% (7.3% to 21.6%) to 6.3% (4.5% to
8.7%). Adding hidden text records did not alter the PPV
of abdominal pain for bladder (codes: 0.14%, 0.13% to
0.16% vs codes plus hidden text: 0.14%, 0.13% to
0.15%) or pancreatic (0.23%, 0.21% to 0.25% vs
0.21%, 0.20% to 0.22%) cancer.
Conclusions: Omission of text records from CPRD
studies introduces bias that inflates outcome measures
for recognised alarm symptoms. This potentially
reinforces clinicians’ views of the known importance of
these symptoms, marginalising the significance of ‘low-
risk but not no-risk’ symptoms.
INTRODUCTION
The Clinical Practice Research Datalink
(CPRD) is a UK-based research service that
maintains a database of anonymised copies
of medical records collected by general prac-
titioners (GPs) as part of everyday clinical
care. The database is the largest of its kind
and a representative sample of the UK popu-
lation. Though created for pharmacological
research, the database is now used exten-
sively in epidemiological studies.1 2 Quality
standards for the CPRD—devised for phar-
macoepidemiology research—have not been
amended to accommodate areas such as
symptom-based research.
One potential, but neglected, concern for
those using CPRD data arises from the way
clinical events are recorded in the GP
surgery. Most GP practices that contribute
data to the CPRD use ViSion software
(ViSion INPS, London, UK), in which GPs
must choose a Read code to begin a record.
Read codes have been used in the National
Health Service to record patient ﬁndings
since 1985, and there are now over 96 000 of
them organised in a hierarchical classiﬁca-
tion system. Once a Read code has been
Strengths and limitations of this study
▪ Set in the Clinical Practice Research Datalink, in
which electronic medical records are recorded
prospectively, eliminating recall bias.
▪ Large study size.
▪ Comprehensive identification of coded records of
cancer symptoms.
▪ Search criteria for identifying text records of
cancer symptoms will have missed US spellings
and spelling errors.
▪ Study did not identify whether text records arose
through the recording practices of a small
number of general practitioner practices.
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chosen, a comments box opens in which GPs can type
freely and are not limited to elaborating on the code.
While codes are fully and routinely available to research-
ers, text records are not. Furthermore, a moratorium on
the collection of text data by the CPRD was introduced
in 2013. Text recorded before 2013 can be accessed by
researchers, but this is rarely performed because the
methods are complex, expensive and limited. Therefore,
to be detected by researchers, clinical information in
the medical record must be recorded using a Read
code. Consequently, the omission of text records may
introduce a ‘detection’ bias, because researchers are
oblivious to clinical events that are only ever recorded as
an inaccessible text comment (henceforth called
‘hidden text’).3
In a previous CPRD case–control study, we identiﬁed
that, of 312 patients with non-visible haematuria, records
of this fact were made solely in hidden text for 219
(59%). The proportional loss of records in the hidden
text was similar in cases and controls. Therefore, the
effect of the detection bias was limited to underestima-
tion of the frequency of non-visible haematuria.4
This paper further investigates the potential conse-
quences for research of having two recording methods
—codes and hidden text. Speciﬁcally, we sought evi-
dence for the disproportionate use of hidden text to
record symptoms/signs presented by cases compared
with controls, as this will result in biased estimates of
outcome measures such as ORs and positive predictive
values (PPVs). This is important, because the outputs of
such research are used as evidence to underpin national
guidelines; for example, estimates of cancer risk in symp-
tomatic patients presenting to primary care.5 6
METHOD
This study extended two CPRD studies conducted by our
group that identiﬁed the features of bladder and pancre-
atic cancer in primary care.5 6 This was deliberate, in
order to investigate whether detection bias affects the
many cancer diagnostic studies conducted since 2000,
all restricting their analysis to coded CPRD data.5–13
Setting, patients and period of study
CPRD data were used in a matched case–control design.
Cases (≥40 years old) had a bladder/pancreatic cancer-
speciﬁc code recorded between 1 January 2000 and 31
December 2009 inclusive. Each case was matched with
up to ﬁve controls on age, sex and GP practice. The
diagnosis date for each case, taken as their earliest
recorded cancer-speciﬁc code, determined the end
point of the 1-year analysis period for each case–control
set. Full inclusion and exclusion criteria for participants
are available in online supplementary appendix 1.
Variables
We examined whether omitting text records from ana-
lysis results in the underestimation of the frequency of
three features of cancer. These were chosen as being
representative of ‘alarm’ or of ‘low-risk but not no-risk’
features of cancer; namely, visible haematuria (an alarm
symptom for bladder cancer), jaundice (an alarm
feature of pancreatic cancer) and abdominal pain (a
low-risk symptom common to both cancers).5 6
Identifying coded records of visible haematuria, jaundice or
abdominal pain
The medical records of all participants were searched
for Read codes for visible haematuria, jaundice and
abdominal pain.
The original bladder cancer study’s list of codes for
visible haematuria was reused.5 Patients whose medical
record contained none of the codes were assumed not
to have experienced this symptom. This process was
repeated using the jaundice code list created in the pan-
creatic cancer study.6
For abdominal pain, which is common to both
cancers, the original studies had used slightly different
code lists. Codes for indigestion and dyspepsia were
included in the pancreatic, but not the bladder, cancer
study. For the study reported here, a uniﬁed abdominal
pain code list was constructed (thus, numbers for
abdominal pain differ slightly from those originally
reported).
Full code lists for visible haematuria, jaundice and
abdominal pain are in online supplementary appendix 2.
Identifying text records of visible haematuria, jaundice or
abdominal pain
CPRD were asked to search the hidden text of all partici-
pants for the following terms (optimised to catch varia-
tions in capitalisation):
▸ Abdominal pain: ‘bdominal pai’, ‘bdo pai’, ‘ain in
abdo’, ‘pigastric pai’;
▸ Jaundice: ‘aundice’, ‘cterus’, ‘cteric’;
▸ Haematuria: ‘aematuria’, ‘lood in urine’.
CPRD anonymised each extract and provided text
strings of the search term plus three words on either
side to aid interpretation.
Generating variables from hidden text extracts
Hidden text extracts were converted to binary variables
(symptom present/absent) using an algorithm run in
Stata. The default classiﬁcation was ‘symptom present’,
and then extracts were classiﬁed as ‘symptom absent’ if
they contained descriptors suggesting symptom negation
(eg, ‘no visible haematuria’), or as ‘uncertain’ if they
contained words suggesting that the meaning may be
unclear (eg, ‘if any’). The classiﬁcation of extracts
ﬂagged as ‘uncertain’ or as ‘symptom present’ was subse-
quently reviewed manually in consultation with WTH
and KB, both practising GPs. If an extract’s meaning
could not be agreed, or it was conﬁrmed that the extract
was uninterpretable, the symptom was deemed to be
absent. Summary information regarding the
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classiﬁcation of all hidden text extracts is provided in
online supplementary appendix 3.
The validity of the classiﬁcation process was assessed
by comparing its output with that of a gold standard.
The gold standard was created using the panel of con-
sensus method, in which WTH and KB independently
rated a random sample of 84 text extracts about visible
haematuria.14 The level of agreement between the algo-
rithm and the gold standard was high (chance-corrected
weighted κ =0.9, 95% CI 0.7 to 1.1). Full details of gold
standard construction are in online supplementary
appendix 3.
Doctors may make spelling and typographical errors
when typing text records. Therefore, the random
sample of text extracts used to create the gold standard
was proofread and checked, and the number of
American and misspellings reported.
Identifying text-only (hidden text) recording
For each patient, date matching of coded and text
records identiﬁed where the GP had recorded visible
haematuria solely in the text, that is, in hidden text.
Binary variables were created to identify occurrences of
visible haematuria that were overlooked in the original
studies because GPs never used a code to record the
event. The process was repeated for jaundice and
abdominal pain records.
Each patient was then categorised by a binary variable
denoting the style used to record their ﬁrst ﬁve atten-
dances for haematuria—subsequent attendances were
omitted as they were so infrequent. ‘Coded’ was assigned
if any record was made in coded form; conversely,
‘hidden text’ was designated only when all instances
were noted solely in the text. This binary variable identi-
ﬁed which patients with at least one episode of visible
haematuria were overlooked in the original studies
because the GP had never used a code to record the
event. The process was repeated for jaundice and
abdominal pain records.
Analysis
Event-level analysis quantiﬁed how many visible haema-
turia records are lost to analysis by identifying the pro-
portion of total records (coded plus hidden text) made
in hidden text. Patient-level analysis quantiﬁed how
many patients with visible haematuria are lost to analysis
because their history of the symptom is always recorded
in hidden text. Event-level and patient-level analyses
were repeated for jaundice and abdominal pain.
Associations between recording style and case–control
status were also examined at the patient level for all fea-
tures in both cancer data sets using the χ2 test (thresh-
old p value <0.05).
The strength of association between a feature and
cancer was assessed using univariable conditional logistic
regression. ORs (95% CI) are reported before and after
addition of previously hidden text records. The chance
of cancer in patients presenting with a feature was esti-
mated by the PPV (Bayes’ theorem), before and after
addition of previously hidden text records.15
All analyses were conducted using Stata (V.13,
StatCorp, College Station, Texas, USA).
RESULTS
Patient characteristics
The participants’ characteristics are given in table 1 (see
original studies for further details).5 6
Processing of text extracts
The CPRD provided 13 853 text extracts containing any
of the search terms listed above in the Methods section.
Details of their classiﬁcation as ‘symptom present’,
‘symptom absent’ and ‘unclear’ are given in online sup-
plementary appendix 3 tables 6 and 7.
The random sample of extracts used to create the
gold standard contained 762 words, of which ﬁve were
misspelt, representing an error rate of 0.7%. No
instances of US instead of UK spelling—for example,
‘anemia rather than ‘anaemia’—were found.
Quantity of data in the hidden text
At the event level, considerable numbers of visible
haematuria, jaundice and abdominal pain records were
made solely in the hidden text in both cancer data sets
(ﬁgure 1) (see also online supplementary appendix 3
tables 6 and 7).
The proportion of records overlooked in the original
studies because they were in the hidden text varied with
the symptom. For visible haematuria, the proportion of
total records made in hidden text was greater in the
pancreatic (251/513=49%) than in the bladder (2699/
7302=37%) cancer data set (ﬁgure 1). In both cancer
data sets, approximately half of all jaundice records and
one-third of all abdominal pain records were made
solely in hidden text (ﬁgure 1). The Read code paired
with hidden text records tended to be administrative
(eg, telephone call), indicating the context of the con-
sultation, or for another clinical problem (eg, another
symptom or a diagnosis).
The patient-level data suggested that hidden text was
used frequently and consistently, such that the original
studies overlooked up to one-third of patients with these
features. For abdominal pain, the proportion of patients
Table 1 Patient characteristics
Cancer
site Case–control
Number (%) in age
group:
<60 years ≥60 years
Bladder Cases (n=4915) 557 (11) 4358 (89)
Controls (n=21 718) 2270 (10) 19 448 (90)
Pancreas Cases (n=3635) 561 (15) 3074 (85)
Controls (n=16 459) 2332 (14) 14 127 (86)
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lost to analysis was similar in both cancer data sets
(bladder: 584/2015=29%; pancreas: 720/2915=25%)
(ﬁgure 2). For alarm features, use of hidden text varied
with the feature’s strength of association with the cancer
subsequently diagnosed in the case. For visible haema-
turia, only 696 of 3483 patients (20%) with this symptom
in the bladder cancer data set were overlooked in the ori-
ginal studies; however, this proportion was doubled (142/
341=42%) in the pancreatic cancer data set. A similar
pattern was observed for jaundice recording.
Associations between case–control status and recording
style of alarm symptoms
For visible haematuria in the bladder cancer data set,
there was a strong association between case–control
status and recording style. The extent of patient loss in
Figure 1 Event-level analysis: numbers of visible haematuria, jaundice and abdominal pain records in bladder and pancreatic
cancer data set, grouped by recording method (dark grey: coded; light grey: solely in the text, ie, hidden text). Numbers of
records are tabulated beneath the graphs, and the total number of records (codes+hidden text) is marked at the top of each bar.
The percentage of records attributed to each recording style is marked on the bars.
Figure 2 Patient-level analysis: numbers of patients with visible haematuria, with jaundice and with abdominal pain in bladder
and pancreatic cancer data sets, grouped by recording method (dark grey: coded; light grey: solely in the text, ie, hidden text).
Numbers of patients are tabulated beneath the graphs, and the total number of patients (codes+hidden text) is marked at the top
of each bar. The percentage of patients attributed to each recording style is marked on the bars. Note: at the patient level,
patients were categorised as having a hidden text recording style if all their attendances were documented solely in the text.
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the hidden text was greater for controls (140/336=42%)
than for cases (556/3147=18%) (χ2 test, p<0.001, ﬁgure
3A, left). However, in the pancreatic cancer data set, the
pattern was reversed in that there was greater loss of cases
with this symptom (51/103=49%) than controls (91/
238=38%) (p<0.05, ﬁgure 3A, right). This reversal of bias
was mainly driven by a large increase in the proportion of
cases rendered as hidden text, the proportional loss of
controls remaining relatively unchanged at ∼40%.
A similar pattern was observed for recording of jaundice
which is strongly associated with pancreatic cancer. The
extent of patient loss in the hidden text was greater for
controls (21/31=67%) than for cases (463/1565=30%) in
the pancreatic cancer data set (p<0.001) (ﬁgure 3B, left).
As above, the bias was reversed in the unconnected
cancer. In the bladder cancer data set, the loss of controls
with jaundice (30/64=47%) was smaller than the loss of
cases (15/21=71%) (p<0.001, ﬁgure 3B, right).
Associations between case–control status and recording
style of ‘low-risk but not no-risk’ symptoms
The association between case–control status and recording
style is reported for abdominal pain in ﬁgure 3C. In the
pancreatic cancer data set, hidden text recording affected
a greater proportion of controls compared with cases (χ2
test, p<0.001), although the size of the difference was rela-
tively small (controls: 323/1126=29% vs cases: 397/
1789=22%). By contrast, in the bladder cancer data set,
the records for ∼30% of controls and cases (p=0.4) were
lost in hidden text (right-hand bars, ﬁgure 3C), mirroring
the pattern seen in pancreatic cancer controls.
Effect on ORs and PPVs
Minimal or no overlap of the CIs suggests that PPV
values for visible haematuria and jaundice in their asso-
ciated cancers were reduced by addition of hidden text
records (table 2). The OR for bladder cancer in patients
presenting with a single episode of visible haematuria
tended to be decreased by addition of hidden text
records, whereas the OR for jaundice was unaffected.
Risk estimates for abdominal pain were not altered by
addition of hidden text records (table 2).
DISCUSSION
Principal findings
This study examined a neglected aspect of using CPRD
data in symptom-based research; namely, loss of data
due to recording style. For large numbers of patients,
GPs record occurrences of visible haematuria, jaundice
or abdominal pain solely in hidden text. Consequently,
restricting analysis to codes underestimates symptom fre-
quency, in patients with and in those without cancer.
This conﬁrms and extends our previous ﬁndings relating
to non-visible haematuria.4
The major new ﬁnding of this study is that, for visible
haematuria and jaundice, recording style choices lead to
differential loss of information in hidden text between
cases and controls. This suggests that most case–control
studies of CPRD data analysing alarm symptoms are
likely to be vulnerable to similar detection biases,
because it is standard practice to restrict analysis to
codes. When identifying patients with alarm symptoms,
Figure 3 (A–C) Patient-level analysis. (A) Number of
patients with visible haematuria in the bladder (left) and
pancreatic (right) cancer data sets, grouped by recording
method (dark grey: coded; light grey: solely in the text, ie,
hidden text) and patient status (case or control). (B) Number
of patients with jaundice in the pancreatic (left) and bladder
(right) cancer data sets grouped by recording method and
patient status. (C) Number of patients with abdominal pain in
the pancreatic (left) and bladder (right) cancer data sets,
grouped by recording method and patient status. Numbers of
patients are tabulated beneath the graphs, and the total
number of patients (codes+hidden text) is marked at the top of
each bar. The percentage of patients attributed to each
recording style is marked on the bars. Note: ***=p<0.001;
*0.05>p>0.01.
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the bias works in favour of those subsequently diagnosed
with cancers speciﬁc to the alarm symptom, and against
those who either do not have, or are diagnosed with an
unconnected, cancer. The detection bias thus artiﬁcially
inﬂates PPV values for alarm symptoms in their asso-
ciated cancers.
For abdominal pain, which is more strongly associated
with pancreatic than with bladder cancer,5 6 a minor
detection bias favours identiﬁcation of cases with abdom-
inal pain, but only in the pancreatic cancer data set.
Risk estimates are unaffected.
The results suggest that GPs are making strong clinical
judgements about the probable signiﬁcance of symp-
toms—preferentially coding clinical features they con-
sider signiﬁcant to a diagnosis, while tending to use
hidden text to record those that they think are not. In
this way, GPs are ﬁltering electronic medical records
available to researchers in favour of established associa-
tions between symptoms and diagnoses.
Strengths and limitations
The main strengths of this study are its large size and
that most clinical records were made at the time of the
consultation, limiting if not eliminating recall bias. This
study, like all those based on medical records, was
limited by reliance on symptom reporting by patients
and subsequent recording by GPs.
The study of hidden text records brought additional
limitations. First, the search criteria will have missed US
spellings (eg, hematuria), and misspellings. However, few
occurred in the random sample that was checked for this.
Second, some errors are inevitable when classifying text
extracts; however, the addition of a manual review of text
strings containing words that indicate uncertainty will
have minimised these. Finally, the thoroughness of the
CPRD’s search methods was not documented but, given
their emphasis on data quality, we have no concerns
about this.2 16 Indeed, if there were any shortcomings in
the CPRD’s search methods, they would be unlikely to
explain the differential loss of information in the hidden
text between cases and controls observed in this study.
Another limitation of the study is that it did not identify
whether the detection bias was caused by the recording
behaviour of a small number of GP practices. However, it
was important to include data from all contributing prac-
tices in order to obtain a measure of bias in CPRD studies
overall. This is because the CPRD does not assess or
provide quality measures about the quantity of data
recorded in hidden text. Indeed, now that text data are no
longer collected (see the Introduction section), the CPRD
is unable to provide this information for researchers.
Comparison with existing literature
Other than our previously published work that identi-
ﬁed text records of non-visible haematuria,4 there are
no directly comparable studies. Comparisons of
numbers of patients overlooked because their records
were made in hidden text are complicated by variations
in the methods that other researchers used to identify
coded records of symptoms. The more comprehensive
the code list used to identify instances of symptoms, the
greater the number of records identiﬁed, and the
smaller the amount of data ‘lost’ in hidden text.
Ford et al estimated loss of clinical information about
rheumatoid arthritis in CPRD hidden text. They identi-
ﬁed text-only recording of symptoms of arthritis; for
example, codes for synovitis were recorded for 179 of
6376 (2.8%) patients, but a search of the text suggested
that this symptom occurred in 1168 (18.3%) patients.17
Their study was limited by the omission to identify if the
text record was ‘positive’ (ie, reporting a current
symptom) or ‘negative’ (ie, referring to an episode in
the past, or conﬁrming the absence of a symptom);
therefore, the extent of data lost to analysis is likely to
be overestimated. Koeling et al18 reported, in conference
proceedings, that adding hidden text records increased
the percentage of ovarian cancer patients with abdom-
inal pain by a factor of 1.4, from 43% to 60%. Our ﬁnd-
ings for abdominal pain were similar, increasing by
factors of 1.4 (from 419/4915 to 600/4915) and 1.3
(from 1392/3635 to 1789/3635) in bladder and pancre-
atic cancer cases, respectively.
Hayward et al19 examined the Consultations in Primary
Care Archive data base (different to the CPRD, but also
with two-tier recording) for breathlessness and wheeze
before a diagnosis of ischaemic heart disease, chronic
obstructive pulmonary disease or asthma. Adding hidden
text records increased the percentage of patients with
recorded breathlessness or wheeze from 30% to 62% in
cases and from 6% to 25% in controls. This suggests a
strong association between recording style and patient
case–control status (χ2 test, p<0.001: our estimate),
Table 2 Odds ratios (OR) and positive predictive values (PPV) for cancer in symptomatic patients.
Cancer site Symptom OR (95% CI) PPV (%) (95% CI)
Codes Total Codes Total
Bladder Visible haematuria 100 (78 to 129) 76 (61 to 95) 4.0 (3.5 to 4.6) 2.9 (2.6 to 3.2)
Abdominal pain 1.9 (1.7 to 2.2) 2.1 (1.9 to 2.3) 0.14 (0.13 to 0.16) 0.14 (0.13 to 0.15)
Pancreas Jaundice 713 (339 to 1499) 640 (354 to 1159) 12.8 (7.3 to 21.6) 6.3 (4.5 to 8.7)
Abdominal pain 14.0 (12.6 to 15.6) 15.4 (13.9 to 17.0) 0.23 (0.21 to 0.25) 0.21 (0.20 to 0.22)
OR and PPV values were estimated first using codes (Codes) solely, and then using codes plus hidden text records (Total).
The OR was estimated using univariable conditional logistic regression. The PPV was estimated using Bayes’ theorem assuming prior odds of
0.0006 for bladder and 0.0003 for pancreatic cancer based on 2008 UK national incidence data.
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although this was not directly reported. This result
mirrors our ﬁndings, and demonstrates that bias arising
from recording method is not unique to the CPRD.
Implications of the findings
The main implication is methodological. Our results will
help researchers to assess whether their studies are likely
to be vulnerable to detection bias associated with use of
hidden text to record symptoms in CPRD studies.
Researchers are advised that recording methods may
artiﬁcially inﬂate risk estimates for alarm symptoms in
their associated diseases, whereas it is not likely to alter
risk estimates for non-alarm symptoms.
The bias demonstrated in this paper only affects high-
risk features. This may not detract from the use of the risk
estimates produced by cancer diagnostic studies,5 6 as
these features already generally invoke action. Indeed, the
‘corrected’ PPVs still lie near, or exceed, the 3% threshold
prompting referral for suspected cancer in the latest UK
national guidelines.20 Importantly, ‘low-risk but not
no-risk’ abdominal pain and non-visible haematuria were
subject to little or no bias, as shown in this and our previ-
ous study.4 Therefore, their risk estimates are unaltered,
and they still meet criteria for inclusion in UK cancer
referral guidance, justifying their recent addition.20 This is
particularly reassuring, because low-risk symptoms are
common and errors in their risk estimation would have
had considerable consequences for the validity of such
estimates. Nonetheless, there is a danger that the inﬂated
risk estimates for alarm features will tend to marginalise
the signiﬁcance of low-risk features of cancer. However, it
is rare for a low-risk feature to be included in isolation in
recommendations for cancer investigation, which typically
include the risk of cancer in patients presenting with two
symptoms concurrently.20 Therefore, it is unlikely that
detection bias due to loss of records in the hidden text will
result in the erroneous omission of a feature from cancer
recommendations.
Finally, this paper has focused on cancer, in part
because it is one of the main areas where CPRD symp-
tomatic research has concentrated. However, it is reason-
able to conclude that our ﬁndings may extend to other
research areas. There is the strong possibility of under-
estimation of symptom frequency possibly coupled with
differential recording between comparison groups in all
CPRD symptom studies. This does not imply that CPRD
symptom-based studies are suspect, but more that they
need to be interpreted carefully.
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